Clinical Trials Logo

Epilepsy, Temporal Lobe clinical trials

View clinical trials related to Epilepsy, Temporal Lobe.

Filter by:

NCT ID: NCT04897776 Active, not recruiting - Clinical trials for Epilepsy, Temporal Lobe

Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy

START
Start date: October 31, 2021
Phase: N/A
Study type: Interventional

The goal is to provide a novel therapeutic option for temporal lobe epilepsy patients when focal impaired awareness seizures cannot be stopped by medications, surgical or laser ablation, or by neurostimulation. The goal is restore consciousness when seizures cannot be stopped. If successful, addition of bilateral thalamic stimulation to existing responsive neurostimulation to rescue consciousness would greatly alter clinical practice and patient outcomes. Importantly, previous approaches aim to stop seizures, whereas this study aims to use thalamic stimulation to improve a major negative consequence when seizures cannot be stopped. The potential impact extends beyond temporal lobe epilepsy to other seizure types, and may also extend more broadly to inform treatment of other brain disorders associated with impaired consciousness and cognition.

NCT ID: NCT04871555 Not yet recruiting - Clinical trials for Epilepsy, Temporal Lobe

Structural Cartography of the Insula in Temporal Epilepsy Patients

CON-INSULA
Start date: June 1, 2021
Phase:
Study type: Observational

The purpose of this study is to investigate insula structural connectivity in temporal epilepsy patients. Insula being at the interface of frontal, parietal, occipital and temporal lobes, its structural organization reflects the brain function. We hypothetize that insular structural organization will be different according to the different subtypes of temporal epilepsy.

NCT ID: NCT04717388 Recruiting - Tinnitus Clinical Trials

Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus

AudiCog
Start date: June 15, 2021
Phase: N/A
Study type: Interventional

the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder. The objective of this project is to study the impact of tinnitus on the cognitive, emotional, psychoacoustic and cerebral functioning associated with this hearing disorder, and to clarify the pathophysiology of tinnitus by comparing different groups of individuals with tinnitus (surgical epileptic patients or non-surgical ORL patients) to matched tinnitus-free groups (surgical tinnitus-free cases and healthy controls volunteer).

NCT ID: NCT04710004 Terminated - Clinical trials for Mesial Temporal Lobe Epilepsy

Electrophysiological Biomarkers in MTLE Patients.

Start date: November 30, 2021
Phase: N/A
Study type: Interventional

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

NCT ID: NCT04649008 Recruiting - Epilepsy Clinical Trials

Localizing Epileptic Networks Using MRI and iEEG

Start date: March 1, 2021
Phase: Early Phase 1
Study type: Interventional

Upon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional dynamics and epilepsy surgical outcomes. Findings from the present study may inform current and new therapies to map and alter seizure spread, and pave the way for less invasive, better- targeted, patient-specific interventions with improved surgical outcomes. This research is relevant to public health because over 20 million people worldwide suffer from focal drug-resistant epilepsy and are potential candidates for cure with epilepsy surgical interventions.

NCT ID: NCT04526418 Recruiting - Epilepsy Clinical Trials

Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Temporal Lobe Epilepsy

Start date: April 21, 2021
Phase: N/A
Study type: Interventional

The 24/7 EEG™ SubQ system will be compared to simultaneously recorded video-EEG in the Epilepsy Monitoring Unit (gold standard) and to self-reported seizure log books throughout 12 weeks of outpatient EEG recording. The present study is a 12-week open-label, prospective study with a paired, comparative design for pivotal evaluation of the safety and effectiveness of the 24/7 EEGTM SubQ system in subjects with temporal lobe epilepsy. 2-5 sites in Europe Up to 5 sites in US, or up to 10 sites if approval granted.

NCT ID: NCT04264780 Completed - Clinical trials for Epilepsy, Temporal Lobe

Epilepsy Surgery and Cognitive Outcome

Start date: August 15, 2019
Phase:
Study type: Observational

This study will give important information about long term consequences of temporal lobe epilepsy surgery on cognition (memory, language, concentration etc), psychiatric function and quality of life.

NCT ID: NCT04169581 Completed - Clinical trials for Epilepsy, Temporal Lobe

A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging

Start date: June 1, 2018
Phase:
Study type: Observational

This study aims to use radiomics analysis and deep learning approaches for seizure focus detection in pediatric patients with temporal lobe epilepsy (TLE). Ten positron emission tomograph (PET) radiomics features related to pediatric temporal bole epilepsy are extracted and modelled, and the Siamese network is trained to automatically locate epileptogenic zones for assistance of diagnosis.

NCT ID: NCT04164056 Recruiting - Clinical trials for Epilepsy, Temporal Lobe

Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy

Start date: November 2019
Phase: Phase 4
Study type: Interventional

The study aims to compare the safety and effectiveness of deep brain stimulation of the hippocampus and the anterior nucleus of the thalamus for reducing the frequency of seizures in patients with bilateral temporal lobe epilepsy.

NCT ID: NCT04055532 Withdrawn - Clinical trials for Amyotrophic Lateral Sclerosis (ALS)

Biomarkers in Neurodegenerative Diseases

Start date: October 1, 2019
Phase:
Study type: Observational [Patient Registry]

The general purpose of this observational study is to examine biomarkers associated with the pathology of neurodegenerative diseases to potentially develop novel therapeutic approaches.